On the advent of MSI testing of all colorectal cancers and a substantial part of other Lynch syndrome-related neoplasms

References

• Vasen HF, Wijnen JT, Menko FH et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology110(4), 1020–1027 (1996).
   PubMed Web of Science ®Google Scholar
• Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J. Med. Genet.36(11), 801–818 (1999).
   PubMed Web of Science ®Google Scholar
• Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam. Cancer4(3), 211–218 (2005).
   PubMed Web of Science ®Google Scholar
• van Lier MG, Wagner A, van Leerdam ME et al. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory. J. Cell. Mol. Med. DOI: 10.1111/j.1582-4934.2009.00977 (2009) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Young WF Jr. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol. Metab. Clin. North Am.29(1), 159–185 (2000).
   PubMed Web of Science ®Google Scholar
• Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology118(5), 829–834 (2000).
   PubMed Web of Science ®Google Scholar
• Schmeler KM, Lynch HT, Chen LM et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N. Engl. J. Med.354(3), 261–269 (2006).
   PubMed Web of Science ®Google Scholar
• Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology116(6), 1453–1456 (1999).
   PubMed Web of Science ®Google Scholar
• Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl Cancer Inst.96(4), 261–268 (2004).
   PubMed Web of Science ®Google Scholar
• Van Lier MG, De Wilt JH, Wagemakers JJ et al. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome. Scand. J. Gastroenterol.44(5), 600–604 (2009).
   PubMed Web of Science ®Google Scholar
• Lindor NM, Petersen GM, Hadley DW et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA296(12), 1507–1517 (2006).
   PubMed Web of Science ®Google Scholar
• Sijmons RH, Boonstra AE, Reefhuis J et al. Accuracy of family history of cancer: clinical genetic implications. Eur. J. Hum. Genet.8(3), 181–186 (2000).
   PubMed Web of Science ®Google Scholar
• Kievit W, de Bruin JH, Adang EM et al. Cost effectiveness of a new strategy to identify HNPCC patients. Gut54(1), 97–102 (2005).
   PubMed Web of Science ®Google Scholar
• De Bruin JH, Ligtenberg MJ, Nagengast FM et al. Optimizing the detection of hereditary non-polyposis colorectal cancer: an update. Scand. J. Gastroenterol.243(Suppl.), 146–152 (2006).
   Web of Science ®Google Scholar
• Hampel H, Frankel WL, Martin E et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J. Clin. Oncol.26(35), 5783–5788 (2008).
   PubMed Web of Science ®Google Scholar
• Mvundura M, Grosse SD, Hampel H, Palomaki GE. The cost–effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet. Med.12(2), 93–104 (2010).
   PubMed Web of Science ®Google Scholar
• Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J. Mol. Diagn.10(4), 293–300 (2008).
   PubMed Web of Science ®Google Scholar
• Shia J, Tang LH, Vakiani E et al. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am. J. Surg. Pathol.33(11), 1639–1645 (2009).
   PubMed Web of Science ®Google Scholar
• Vasen HF, Moslein G, Alonso A et al. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam. Cancer (2009) (Epub ahead of print).
   Google Scholar
• Overbeek LI, Ligtenberg MJ, Willems RW et al. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am. J. Surg. Pathol.32(8), 1246–1251 (2008).
   PubMed Web of Science ®Google Scholar
• Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet. Med.11(1), 35–41 (2009).
   PubMed Web of Science ®Google Scholar
• Halvarsson B, Lindblom A, Rambech E, Lagerstedt K, Nilbert M. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? Virchows Arch.444(2), 135–141 (2004).
   PubMed Web of Science ®Google Scholar
• Ferreira AM, Westers H, Sousa S et al. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients. J. Pathol.219(1), 96–102 (2009).
   PubMed Web of Science ®Google Scholar
• Bacher JW, Flanagan LA, Smalley RL et al. Development of a fluorescent multiplex assay for detection of MSI-high tumors. Dis. Markers20(4–5), 237–250 (2004).
   PubMed Web of Science ®Google Scholar
• Suraweera N, Duval A, Reperant M et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology123(6), 1804–1811 (2002).
   PubMed Web of Science ®Google Scholar
• Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol.23(3), 609–618 (2005).
   PubMed Web of Science ®Google Scholar
• Newton K, Hill J. 5-FU and mismatch repair deficient colorectal cancer: is it time to consider a change in practice? Colorectal Dis. (2010) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Bertagnolli MM, Niedzwiecki D, Compton CC et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J. Clin. Oncol.27(11), 1814–1821 (2009).
   PubMed Web of Science ®Google Scholar
• Zlobec I, Kovac M, Erzberger P et al. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer. Int. J. Cancer DOI: 10.1002/ijc.25265 (2010) (Epub ahead of print).
   Google Scholar
• Zighelboim I, Schmidt AP, Gao F et al. ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes. J. Clin. Oncol.27(19), 3091–3096 (2009).
   PubMed Web of Science ®Google Scholar